Please assess the completion status of the following clinical trial:

Trial Title: Oscillatory Contributions to Working Memory and Attention

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age of # 18 \<36. - Right-handed.~* Be in good health determined by the investigator on basis of medical history, physical and neurological exam; for EEG-only sessions no physical or neurological exams will be performed;~* Female subjects must be two years past menopause, surgically sterile or practicing a medically acceptable method of birth control (does not apply to EEG-only sessions);~* Female subjects must not be pregnant.~* Able to understand and speak English.~* Able to provide written consent prior to admission~Exclusion Criteria:~* History of epilepsy, stroke, brain surgery, cranial metal implants, structural brain lesion, devices that may be affected by TMS or tCS(pacemaker, medication pump, cochlear implant, implanted brain stimulator); - Women who are breast-feeding (self report)\*;~* History of head trauma with loss of consciousness for greater than 5 minutes;~* Any history of seizures;~* Any family history of seizures\*;~* Diabetes requiring insulin treatment\*;~* A serious heart disorder or subjects who have had a heart attack within the last 3 months;~* Subjects who meet DSM-IV criteria for alcohol /drug abuse problems within the last six months;~* Any current Axis I or II diagnoses or past Axis I diagnoses;~* Required use of medication that affects CNS function;~* A subject with metallic implants, such as prostheses, shrapnel or aneurysm clip-S, or persons with electronic implants, such as cardiac pacemakers. The magnetic field generated by the MR machine can cause a displacement or malfunctioning of these devices\*;~* The female subject who is pregnant or planning to become pregnant; or a female subject of child-bearing potential who is not practicing a medically acceptable form of birth control\*;~* The subject has had a diagnosis of cancer in the past 3 years and/or has active neoplastic disease;~* The investigator anticipates that the subject will be unable to comply with the protocol.~* Prohibited Concomitant Treatment: Any investigational medication; antipsychotic, antidepressant; or ECT; Other psychotropic medications including sedative hypnotics (excluding chloral hydrate zaleplon); sumatriptan (and similar agents); anxiolytics and herbals (e.g., St. John's Wort, Kava Kava); an introduction or change in intensity of psychotherapy; any nonpsychopharmacologic drug with psychotropic effects (e.g., antihistamines, beta blockers).~* Colorblindness~* Poor or Uncorrected Vision~* History of fainting/syncope

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- 2016-0500-Healthy YoungAdults (Type: EXPERIMENTAL): working memory and attention

Based on this trial design, predict the completion outcome and termination type (if applicable).